Moderna Past Performance

How has Moderna performed over the past 5 years?

Past Performance Score


Past Performance Score 3/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: MRNA has a high level of non-cash earnings.

Growing Profit Margin: MRNA's current net profit margins (55%) are lower than last year (59.7%).

Past Earnings Growth Analysis

Earnings Trend: MRNA has become profitable over the past 5 years, growing earnings by 84.8% per year.

Accelerating Growth: MRNA's earnings growth over the past year (66.6%) is below its 5-year average (84.8% per year).

Earnings vs Industry: MRNA earnings growth over the past year (66.6%) exceeded the Biotechs industry 60.8%.

Return on Equity

High ROE: MRNA's Return on Equity (65.4%) is considered outstanding.

Discover strong past performing companies